Single P2Y₁₂ inhibitor therapy directly after PCI in NSTEMI - a pilot study - PACE-CME

Single PY inhibitor therapy directly after PCI in NSTEMI a pilot study

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Continuation or interruption of OAC during TAVI?
Continuation or interruption of OAC during TAVI?
ESC Congress 2024
Continuation or interruption of OAC during TAVI?
- Dirk Jan van Ginkel, MD
Results with novel FXI inhibitor in AF set the stage for phase 3 trials
Results with novel FXI inhibitor in AF set the stage for phase 3 trials
AHA 2023
Results with novel FXI inhibitor in AF set the stage for phase 3 trials
- Christian Ruff, MD
Lower stroke risk with DOAC vs. aspirin in subclinical atrial fibrillation
Lower stroke risk with DOAC vs. aspirin in subclinical atrial fibrillation
AHA 2023
Lower stroke risk with DOAC vs. aspirin in subclinical atrial fibrillation
- Jeff Healey, MD
International survey of secondary prevention of CHD
International survey of secondary prevention of CHD
ESC Congress 2023
International survey of secondary prevention of CHD
- John W. McEvoy, MD, PhD
- Joris Holtrop, MD